741721-49-3

Basic information

• Product Name: 2,5-difluoro-3-nitrobenzoic acid
• Synonyms: 2,5-difluoro-3-nitrobenzoic acid
• CAS NO: 741721-49-3
• Molecular Formula: C₇H₃F₂NO₄
• Molecular Weight: 203.0998264
• Mol File: 741721-49-3.mol
• Article Data: 6

Chemical Properties

• Boiling Point: 346.8±42.0 °C(Predicted)
• Appearance: /
• Density: 1.661±0.06 g/cm3(Predicted)
• Storage Temp.: Sealed in dry,Room Temperature
• PKA: 1.98±0.20(Predicted)
• CAS DataBase Reference: 2,5-difluoro-3-nitrobenzoic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 2,5-difluoro-3-nitrobenzoic acid(741721-49-3)
• EPA Substance Registry System: 2,5-difluoro-3-nitrobenzoic acid(741721-49-3)

Safety Data

• Hazardous Substances Data: 741721-49-3(Hazardous Substances Data)

Usage

General Description

2,5-difluoro-3-nitrobenzoic acid is a chemical compound with the molecular formula C7H3F2NO4. It is a derivative of benzoic acid with two fluorine atoms and a nitro group attached to the benzene ring. 2,5-difluoro-3-nitrobenzoic acid is commonly used as a building block in the synthesis of various pharmaceuticals, agrochemicals, and organic materials. It is also a potential candidate for use in the development of new drugs due to its unique chemical properties. Additionally, 2,5-difluoro-3-nitrobenzoic acid has been studied for its potential applications in materials science and as a precursor in organic synthesis. Its versatile nature and reactive functional groups make it a valuable compound for various research and industrial applications.

Upstream product

• 2991-28-8 2,5-difluorobenzoic acid 

Downstream Products

• 1154278-08-6 methyl 2,5-difluoro-3-nitrobenzoate 
• 741721-51-7 1-bromo-2,5-difluoro-3-nitrobenzene 

Relevant articles and documents

RAF INHIBITOR COMPOUNDS AND METHODS OF USE THEREOF

Compounds of Formula (I) are useful for inhibition of Raf kinases. Methods of using compounds of Formula (I) and stereoisomers, tautomers and pharmaceutically acceptable salts thereof, for in vitro, in situ, and in vivo diagnosis, prevention or treatment

N- (6-AMINOPYRIDIN-3-YL) -3- (SULFONAMIDO) BENZAMIDE DERIVATIVES AS B-RAF INHIBITORS FOR THE TREATMENT OF CANCER

Compounds of Formula (I) are useful for inhibition of Raf kinases. Methods of using compounds of Formula I and stereoisomers and pharmaceutically acceptable salts thereof, for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions are disclosed.

Synthesis and structure-activity studies of novel benzocycloheptanone oxazolidinone antibacterial agents

We describe a novel class of benzocycloheptanone derived oxazolidinone antibacterial agents. The synthesis and antibacterial activities with structure variation is discussed.